Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $35.46 USD
Change Today +0.10 / 0.28%
Volume 396.1K
HRTX On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen R. Davis J.D.

AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 7 different industries.

See Board Relationships


Mr. Stephen R. Davis, also known as Steve, J.D., has been the Chief Financial Officer, Chief Business Officer and Executive Vice President of ACADIA Pharmaceuticals, Inc. since July 15, 2014 and its Interim Chief Executive Officer since March 2015. Mr. Davis served as the Chief Operating Officer and Executive Vice President of Heron Therapeutics, Inc. from May 2, 2013 to July 2, 2014. He served as Chief Financial Officer and Chief Accounting Officer of Heron Therapeutics, ...

Read Full Background

Corporate Headquarters*

123 Saginaw Drive
Redwood City, California 94063

United States

Phone: 650-366-2626
Fax: --

Board Members Memberships*

Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
Director and Chairman of Audit Committee


Vanderbilt University
Southern Nazarene University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$245,607

Stock Options*

All Other Compensation$308
Unexercisable Options320,000
Total Number of Options320,000

Total Compensation*

Total Annual Cash Compensation$245,915
Total Short Term Compensation$245,607
Other Long Term Compensation$308
Total Calculated Compensation$5,208,923
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HRTX:US $35.46 USD +0.10


Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HERON THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at